Uptake of the Biologic Filgrastim and Its Biosimilar Product Among the Medicare Population
2018
This study uses Medicare part B billing data to compare trends in the use of filgrastim and its biosimilars among beneficiaries between 2014 and 2016.
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
2
References
18
Citations
NaN
KQI